These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 11522091

  • 21. Serum ratio of heart-type fatty acid-binding protein to myoglobin. A novel marker of cardiac damage and volume overload in hemodialysis patients.
    Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Nakata T, Shimamoto K.
    Nephron Clin Pract; 2003; 93(2):C69-74. PubMed ID: 12616033
    [Abstract] [Full Text] [Related]

  • 22. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.
    Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508
    [Abstract] [Full Text] [Related]

  • 23. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
    Sayama H, Nakamura Y, Saitou N, Doi Y, Matsukura S, Sakurai H, Kinoshita M.
    Nihon Ronen Igakkai Zasshi; 1998 Nov 15; 35(11):851-7. PubMed ID: 10064973
    [Abstract] [Full Text] [Related]

  • 24. Kinetics of atrial and brain natriuretic peptides during hemodialysis are regulated in association with different cardiac functional changes.
    Horio T, Ito S, Fujimoto K, Izumiya Y, Yoshiyama M, Iwashima Y, Nakamura S, Yoshihara F.
    Heart Vessels; 2022 Jul 15; 37(7):1146-1152. PubMed ID: 35001145
    [Abstract] [Full Text] [Related]

  • 25. No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation.
    Wozakowska-Kaplon B, Opolski G.
    Pacing Clin Electrophysiol; 2005 Jan 15; 28 Suppl 1():S110-4. PubMed ID: 15683475
    [Abstract] [Full Text] [Related]

  • 26. Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients.
    Yoshihara F, Horio T, Nakamura S, Yoshii M, Ogata C, Nakahama H, Inenaga T, Kangawa K, Kawano Y.
    Kidney Int; 2005 Sep 15; 68(3):1355-63. PubMed ID: 16105071
    [Abstract] [Full Text] [Related]

  • 27. Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis.
    Ishikura F, Ando Y, Park YD, Tani A, Shirai D, Matsuoka H, Miyatake K.
    Ren Fail; 1996 Mar 15; 18(2):261-70. PubMed ID: 8723364
    [Abstract] [Full Text] [Related]

  • 28. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T.
    Int J Cardiol; 2005 Oct 10; 104(3):332-7. PubMed ID: 16186065
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K, Burnett JC, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM.
    Hypertension; 1996 Dec 10; 28(6):988-94. PubMed ID: 8952587
    [Abstract] [Full Text] [Related]

  • 32. [BNP and echocardiographic parameters in patients with chronic kidney disease and dialyzed patients].
    Valociková I, Valocik G, Kristofová B, Druzbacká L, Roland R, Mitro P.
    Vnitr Lek; 2009 Oct 10; 55(10):934-9. PubMed ID: 19947237
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, Bellanuova I, Tripepi R, Seminara G, Parlongo S, Stancanelli B, Bonanno G, Fatuzzo P, Rapisarda F, Belluardo P, Signorelli SS, Heublein DM, Lainchbury JG, Leskinen HK, Bailey KR, Redfield MM, Burnett JC.
    Mayo Clin Proc; 2001 Nov 10; 76(11):1111-9. PubMed ID: 11702899
    [Abstract] [Full Text] [Related]

  • 36. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients].
    Shao YH, Lai YQ, Lin AZ, Kong YZ.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul 10; 25(7):892-4. PubMed ID: 16027094
    [Abstract] [Full Text] [Related]

  • 37. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C, Metzele A, Kochs M, Hombach V, Grünert A.
    Clin Cardiol; 1993 Jul 10; 16(7):553-7. PubMed ID: 8348764
    [Abstract] [Full Text] [Related]

  • 38. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS, Klouche K, Fareh J, Barazer I, Villard-Saussine S, Dupuy AM, Leray-Moragues H, Giuliani I, Canaud B, Cristol JP.
    Clin Chem Lab Med; 2008 Jul 10; 46(7):1019-24. PubMed ID: 18624622
    [Abstract] [Full Text] [Related]

  • 39. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
    Irzmanski R, Barylski M, Banach M, Piechota M, Kowalski J, Cierniewski C, Pawlicki L.
    Med Sci Monit; 2007 Oct 10; 13(10):CR449-56. PubMed ID: 17901852
    [Abstract] [Full Text] [Related]

  • 40. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM, Pinto F, Ravara L, van Zwieten PA.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 10; 5(3):121-9. PubMed ID: 15526247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.